Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction

Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a comparison between autologous bone marrow-derived mononuclear cells (BMMNC) and mesenchymal stem cells (MSC) on therapeutic efficacy after MI wa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cardiovasc Transl Res
Autori principali: van der Spoel, T. I. G., Gathier, W. A., Koudstaal, S., van Slochteren, F., of Lorkeers, S. Jansen, Sluijter, J. P. G., Hoefer, I. E., Steendijk, P., Cramer, M. J. M., Doevendans, P. A., van Belle, E., Chamuleau, S. A. J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623074/
https://ncbi.nlm.nih.gov/pubmed/26382088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-015-9643-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi